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Translational outcomes in a full gene deletion of
ubiquitin protein ligase E3A rat model of
Angelman syndrome
E. L. Berg 1, M. C. Pride1, S. P. Petkova1, R. D. Lee1, N. A. Copping1, Y. Shen1, A. Adhikari1, T. A. Fenton1, L. R. Pedersen1,
L. S. Noakes2, B. J. Nieman2, J. P. Lerch3, S. Harris4, H. A. Born 4, M. M. Peters5, P. Deng6, D. L. Cameron6, K. D. Fink6,
U. Beitnere7, H. O’Geen7, A. E. Anderson4, S. V. Dindot8, K. R. Nash5, E. J. Weeber5, M. Wöhr 9, J. Ellegood 2,
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Abstract
Angelman syndrome (AS) is a rare neurodevelopmental disorder characterized by developmental delay, impaired
communication, motor deficits and ataxia, intellectual disabilities, microcephaly, and seizures. The genetic cause of AS
is the loss of expression of UBE3A (ubiquitin protein ligase E6-AP) in the brain, typically due to a deletion of the
maternal 15q11-q13 region. Previous studies have been performed using a mouse model with a deletion of a single
exon of Ube3a. Since three splice variants of Ube3a exist, this has led to a lack of consistent reports and the theory that
perhaps not all mouse studies were assessing the effects of an absence of all functional UBE3A. Herein, we report the
generation and functional characterization of a novel model of Angelman syndrome by deleting the entire Ube3a
gene in the rat. We validated that this resulted in the first comprehensive gene deletion rodent model. Ultrasonic
vocalizations from newborn Ube3am−/p+ were reduced in the maternal inherited deletion group with no observable
change in the Ube3am+/p− paternal transmission cohort. We also discovered Ube3am−/p+ exhibited delayed reflex
development, motor deficits in rearing and fine motor skills, aberrant social communication, and impaired touchscreen
learning and memory in young adults. These behavioral deficits were large in effect size and easily apparent in the
larger rodent species. Low social communication was detected using a playback task that is unique to rats. Structural
imaging illustrated decreased brain volume in Ube3am−/p+ and a variety of intriguing neuroanatomical phenotypes
while Ube3am+/p− did not exhibit altered neuroanatomy. Our report identifies, for the first time, unique AS relevant
functional phenotypes and anatomical markers as preclinical outcomes to test various strategies for gene and
molecular therapies in AS.
Introduction
Angelman syndrome (AS) is a rare neurodevelopmental
disorder characterized by developmental delay, impaired
communication skills, ataxia, motor and balance deficits,
poor attention, intellectual disabilities, microcephaly, and
seizures1–3. AS is caused by loss-of-expression or loss-of-
function of the maternally inherited allele of the Ubiquitin
protein ligase E3A (UBE3A E6-AP), which typically arises
through a de novo deletion in the maternal 15q11-q13
region4–6. Owing to genomic imprinting, the paternal
allele is silenced in neurons of the central nervous system
(CNS). Angelman syndrome is thus caused by loss of
UBE3A in neurons of the CNS7.
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The Foundation for Angelman Syndrome Therapeutics
(FAST) funded the generation of a genetic rat model of
AS via a 90-kb deletion on chromosome 1, which includes
the entire Ube3a gene. This has opened new possible
avenues of research into the neurobiological and beha-
vioral effects of loss of all isoforms of UBE3A and, cru-
cially, the development of novel therapeutics in the near
future, including gene replacement therapies. This unique
rat model of AS also provides opportunities to investigate
complex AS relevant behaviors that have been difficult to
capture with highsignal sensitivity, rigor, and reproduci-
bility in mice, such as behaviors across developmental
time points, juvenile acoustic social communication, and
cognitive dysfunction.
Well-validated tools for behavioral and functional out-
comes for neurodevelopmental disorders have been well
standardized8, but sophisticated social communication,
translationally relevant learning and memory, and other
AS-symptom domains are less developed in mice9. One
prominent example is the less complex acoustic com-
munication system in the mouse. Rats emit uniquely
detectable ultrasonic vocalizations (USV) that serve as
situation-dependent evolved signals and that accomplish
important communicative functions as alarm or social
contact calls10–12. Another advantage of a rat model is the
ability to utilize advanced cognitive tests for measuring
learning and memory. Examining cognitive functions in
an evolutionarily advanced species13,14 through the use of
behavioral tests highly relevant to clinical diagnostic
assays may improve translational predictability.
The present experiments aimed to take advantage of the
first generated rat model of a complete Ube3a deletion
and define behavioral and anatomical phenotypes by uti-
lizing our comprehensive battery of standardized and
innovative outcome measures to identify functional out-
comes relevant to AS. Using sophisticated and nuanced
behavioral readouts of isolation-induced USV, juvenile
social communication via USV playback, computerized
touchscreen learning and memory, and magnetic reso-
nance imaging (MRI), we evaluated various aspects of
social communication, cognition, and behavior during
development in the AS rat model.
Results
Model generation
The Ube3am−/p+ rat line (background Sprague-Dawley)
was originally designed by the Segal laboratory using the
CRISPR-Cas9 system, generated by Transposagen (Fig.
S1). Two genomic RNAs (gRNAs) were designed to target
the 5ʹ-end of the Ube3a gene (upstream of the Ube3a
coding sequence) and two gRNAs target sequences
downstream of Ube3a. gRNA pairs were used on each end
of the deletion to maximize the probability of a complete
deletion of the 90-kb region encompassing the Ube3a
gene. 5′ CRISPR-1 Target site GGCCCTGCAGAGATGC
AATC, 5′CRISPR-2 Target site GGAGCCCTCCGC
CGGCA, 3′CRISPR-1 Target site TACCCTTCCCA
GGCCCC, and 3′CRISPR-2 Target site GCATTTCT
AGTACATCATCC. In addition, a bridging DNA frag-
ment was constructed with 600-bp homology to the
sequence upstream and homology to 1-kb downstream of
the deletion. The Rnor_6.0 genome build coordinates of
homology arms are 116587209–116587779 and
116678173–116679214, respectively. CRISPR/gRNA
complexes were co-injected with the “bridging construct”
into fertilized Sprague-Dawley rat embryos and inserted
into a surrogate. Founders were screened for deletion of
the entire 90-kb region and germline transmission was
confirmed using genotyping primers (Ube3aDel-F:
5′-ACCTAGCCCAAAGCCATCTC-3′ and Ube3aDel-R:
GGGAACAGCAAAAGACATGG-3′). Junction of dele-
tion of the entire Ube3a gene (~90 kb) was confirmed by
Sanger sequencing (Fig. S1). Deletion was further vali-
dated by Western blotting (Fig. S2). For transparency, we
do have knowledge via foundation collaboration and
conference presentations that another laboratory has
access to these novel AS rats and is working on adult
characterization and long-term potentiation (personal
communication).
Reduced isolation-induced pup ultrasonic vocalizations
(USV) and delayed neonatal reflex development in
Ube3am−/p+ pups
Pup ultrasonic vocalizations (USV) of infant rats and
mice measure an early communicative behavior between
pups and mother. Isolation-induced USV were collected for
3min as social communication signals in rat pups on
postnatal day (PND) 4, 6, 8, 10, 12, 14, 16, and 18, as
previously described15. Ube3am−/p+ pups emitted sig-
nificantly fewer USV across early development compared to
wildtype Ube3am+/p+ littermate controls (Fig. 1a F(1, 67)=
10.80, p < 0.002). Holm-Sidak corrected posthoc analysis
for multiple comparisons highlights PND 10 and PND 12
as reduced in the Ube3am−/p+ compared to Ube3am+/p+
littermates (PND 10: p= 0.0023; PND 12: p= 0.022) with
a trend on PND 14 (p= 0.091). Ube3am−/p+ pups also
emitted significantly fewer USV on PND 8 in the Baylor
laboratory compared to wildtype Ube3am+/p+ littermate
controls, independently reproducing our results (Fig. S3
t(1, 23)= 2.991, p < 0.007). Body weight and temperature
were also collected to assure that the reduced USV were
not the result of being physically smaller as body weight is
known to alter pup USV emission16,17. Weight did not
differ between genotypes (Fig. 1b F(1, 67)= 0.154, p > 0.05)
indicating typical growth and ability to thrive. As expec-
ted, pups with paternal inheritance of the deletion
(Ube3am+/p−) did not have reductions in USV emissions
(Fig. 1c F(1, 58)= 3.555, p > 0.05) or body weight across
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early development (Fig. 1d F(1, 58)= 0.140, p > 0.05),
compared to wildtype Ube3am+/p+ littermate controls.
Body temperature did not differ between genotypes
(Ube3am−/p+ versus Ube3am+/p+: F(1, 67)= 3.859, p > 0.05
and Ube3am+/p− versus Ube3am+/p+: F(1, 58)= 0.038, p >
0.05). Supplementary Tables S1 and S2 show mostly
typical early physical development and neurological
reflexes in various parameters in Ube3am−/p+ versus
Ube3am+/p+ littermates. Interestingly, longer latencies to
navigate upright in negative geotaxis, a simple metric for
motoric, postural, and proprioceptive processes that
underlie the ability of infant rodents to navigate on an
inclined plane, was robustly delayed in the Ube3am−/p+
versus Ube3am+/p+ (Fig. 1e F(1, 88)= 37.22, p < 0.0001).
Longer latencies were observed for 6 of the 8 days tested
(Bonferroni-corrected p < 0.05): PND 4, 6, 8, 10, 12, and
18. Yet, similar latencies to flip over 180 degrees from
supine to prone in the test of righting reflex were
observed (Fig. 1f F(1, 71)= 0.651, p= 0.422).
Reduced vertical activity, poor rotarod performance, and
long latencies to remove adhesive illustrate poor gross
and fine motor abilities in Ube3am−/p+ rats
Motor abilities were tested in an open field assay,
assessing cm2 of horizontal and vertical movements using
beam breaks and time spent in the center of the arena. At
PND 19, Ube3am−/p+ juvenile rats exhibited normal
horizontal activity (Fig. 2a F(1, 71)= 0.1866, p > 0.05) yet
significantly reduced vertical activity (Fig. 2b F(1, 71)=
18.55, p < 0.0001) compared to wildtype Ube3am+/p+ lit-
termate controls for every 5-min time bin across the 30-
min task. No genotype differences were detected in center
time measures at either the early or later developmental
time points (Fig. 2c PND 19 F(1, 71)= 0.1866,
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Fig. 1 Reduced isolation-induced pup ultrasonic vocalizations and delayed neonatal reflex development in Ube3am−/p+ pups. a Ube3am−/p+
pups emitted significantly fewer USV across early development compared to wildtypes, and b demonstrated normal weight gain. c Ube3am+/p− pups
emitted normal numbers of USV across early development, and d also demonstrated normal weight gain. e Compared to wildtype littermates,
Ube3am−/p+ pups were significantly slower in the negative geotaxis test but f had normal latencies to flip over in the test of righting reflex. All analyses
include males and females. Mean +/− S.E.M. is depicted. a–f: *p < 0.05, repeated measures ANOVA, main effect of genotype.
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p > 0.05 and Fig. 2f PND 40 F(1, 71)= 1.397, p > 0.05).
Young-adult (PND 40) Ube3am−/p+ rats exhibited normal
horizontal activity (Fig. 2d F(1, 71)= 1.266, p > 0.05) yet
significantly reduced vertical activity (Fig. 2e F(1, 71)=
5.882, p < 0.02) compared to wildtype Ube3am+/p+ litter-
mate controls. In the adhesive removal task, Ube3am−/p+
rats were significantly slower to initiate removal of the
sticker (Fig. 2g t= 2.986, df= 16, p < 0.009), and trended
slower to complete adhesive removal (Fig. 2h t= 2.032, df
= 16, p= 0.059), suggesting fine motor skill deficits of the
fore paws; the Ube3am−/p+ rats were 48.63+/− 23.93 sec
slower to finish removing the adhesive. Ube3am−/p+ rats
had normal rotarod performance on the first 2 days of
testing but were significantly faster to fall off the rotarod
on the third day compared to wildtypes (Fig. 2i time ×
genotype interaction: F(2, 96)= 7.339, p= 0.001; day 3
Holm-Sidak p= 0.0197), highlighting a motor learning
deficit.
Reduced exploration of pro-social 50-kHz USV in Ube3am−/p+
juvenile rats
Distance traveled in response to the white noise control
stimulus did not differ between groups and both geno-
types exhibited behavioral inhibition (i.e., a reduction in
motion following the noise control) (Fig. 3a genotype
F(1, 68)= 2.548, p > 0.05). As shown by our laboratory and
others previously15,18–22, a striking increase in social
exploratory behavior (i.e., distance traveled) was observed
in response to playback of pro-social 50-kHz USV. Dis-
tance traveled increased in response to playback of 50-
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Fig. 2 Reduced vertical activity and motor learning deficit in Ube3am−/p+ rats. a At PND 19, Ube3am−/p+ juvenile rats exhibited normal
horizontal activity but b had significantly reduced vertical activity compared to wildtypes. c Center time did not differ between groups. d At PND 40,
Ube3am−/p+ rats again exhibited normal horizontal activity, e significantly lower vertical activity, and f normal center time. Note: the difference in axis
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kHz USV (i.e., higher during playback compared to the
minute prior) in Ube3am+/p+ and Ube3am−/p+ rats (Fig.
3b paired t-test Ube3am−/p+: t(1, 38)= 5.271, p < 0.0001
and paired t-test Ube3am+/p+: t(1, 14)= 4.94, p < 0.0001,
respectively), as expected. Interestingly, however, the
magnitude of the distance increase in the Ube3am−/p+
juvenile rats was significantly lower than in the wildtype
Ube3am+/p+ littermates (Fig. 3b genotype F(1, 68)= 4.908,
p < 0.04, Bonferroni correction p < 0.05, for minutes 1 and
2 post call play).
Social exploratory behavior displayed by Ube3am+/p+
rats was clearly directed towards playback of pro-social 50-
kHz USV, as reflected in the more sensitive parameter of
time spent on the arms proximal to the sound source
emitting 50-kHz USV. Ube3am+/p+ rats spent significantly
longer on the arms proximal to the speaker emitting the 50-
kHz USV upon playback and for minutes afterwards (Fig. 3c
F(1, 60)= 7.471, p < 0.01, Bonferroni-corrected p < 0.05 for
minutes 1, 2, and 5). In contrast, the Ube3am−/p+ rats failed
to show a sustained preference and only spent significantly
more time on the proximal arms during the minute of the
USV playback (Fig. 3d F(1, 60)= 3.380, p > 0.05). Fig. 3e, f
show representative heat maps of the distance and direction
traveled in response to the 50-kHz stimuli by Ube3am+/p+
and Ube3am−/p+ respectively. These figures illustrate the
striking increase in directed social exploratory behavior
quantified in Fig. 3c and the lower, atypical pattern of social
exploration quantified in Fig. 3d.
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Fig. 3 Atypical social communication in Ube3am−/p+ juveniles using 50-kHz pro-social ultrasonic vocalizations. a Distance traveled in
response to the white noise control stimulus (gray zone) did not differ between groups: both exhibited behavioral inhibition (i.e., a reduction in
motion following the noise control). b Distance traveled increased in response to playback of 50-kHz USV (gray zone) in Ube3am−/p+ and Ube3am+/p+
rats. Interestingly, the duration of the response was shorter in Ube3am−/p+ compared to that of wildtypes. c In the radial maze used, time spent in the
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Ube3am−/p+ but not Ube3am+/p− illustrate
neuroanatomical pathology at PND 21
Total brain volumes were not observed to be different
between groups, but there was a trend found in the dif-
ference between the Ube3am−/p+ and Ube3am+/p+ litter-
mates (−3.5% in Ube3am−/p+, p= 0.06, q= 0.10).
Structural differences were further examined on a regio-
nal and voxelwise level. In the Ube3am−/p+ rats, several
regional differences were observed voxelwise in both
absolute and relative volume at a false discovery rate
(FDR) of q < 0.15 (Fig. 4). Regionally, when the 98 differ-
ent regions were examined, there were no differences
found in absolute volume for the full group, males, or
females. However, there were several trends in the com-
bined group. The majority of the 98 different regions were
decreased in size in comparison to their wildtype coun-
terparts by −3 to −5%. This led to trends in several dif-
ferent areas of interest. For example, the primary motor
cortex appears to be smaller in the Ube3am−/p+ rats
(−3.6%, p= 0.046, q= 0.10), however, this effect is not
observed upon controlling for multiple comparisons.
Similar findings were seen in the cerebellum, with the
cerebellar lobules decreased in size by −3.8 to −4.6% and
p-values ranging from 0.03 to 0.05; however, again these
trends were not considered significant based on FDR
thresholds (Supplementary Table S3). Dividing the groups
into different sexes revealed that the females seemed to be
driving these volume differences; however, no sex by
genotype interaction was found to be statistically sig-
nificant. In contrast to these results, when examined on a
Fig. 4 Neuroanatomical pathology in Ube3am−/p+ rats at PND 21. Representative coronal slice series highlighting regional brain differences in
absolute (mm3) and relative (%) brain volume between Ube3am−/p+ and Ube3am+/p+ (left) and between Ube3am+/p− and Ube3am+/p+ (right).
Regions with decreased volume in Ube3am−/p+ include the cerebral cortex, cerebellum, and amygdala. Regions with increased volume in Ube3am−/p
+ include the periacqueductal gray, thalamus, and hypothalamus. Ube3am+/p− did not exhibit altered neuroanatomy compared to wildtype. Analyses
include both males and females.
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regional or voxelwise basis, no differences were present
between Ube3am+/p− rats and their Ube3am+/p+ litter-
mates, highlighting a distinct phenotype based on parental
allele inheritance, as expected given the genetic paternal
imprinting of Ube3a.
Ube3am−/p+ rats exhibit deficits in touchscreen
discrimination learning and memory
Given a limited number of testing chambers, for feasi-
bility our initial touchscreen experiments were selectively
performed in males. Ube3am−/p+ required significantly
more training days to learn to discriminate two images
displayed on the touchscreen. Representative task images
are shown in Fig. 5a. Analysis of survival curves (i.e.,
percentage of rats that reached the 80% accuracy criterion
on each training day) indicated that Ube3am+/p+ wildtype
control male rats took about 10–15 sessions to reach
criterion while Ube3am−/p+ rats took about
20–40 sessions (Fig. 5b Log-rank (Mantel-Cox) test: Chi
square= 15.70, df= 1, p < 0.001). Analysis of additional
parameters indicated that Ube3am−/p+ rats illustrate
robust learning and memory impairments. Ube3am−/p+
rats took more sessions (Fig. 5c t(1, 12)= 5.281, p < 0.001),
required more trials (Fig. 5d t(1, 12)= 4.055, p < 0.002),
required a greater number of incorrect responses (Fig. 5e
t(1, 12)= 4.003, p < 0.002), and needed more correction
trials (Fig. 5f t(1, 12)= 4.255, p < 0.002) to reach the
learning criterion. Motivational control parameters such
as numbers of trials completed per session did not differ
between genotypes, also showing no motor impairments
(Fig. 5g t(1, 12)= 0.018, p > 0.05). Panel h is the latency or
time it takes for the rat to collect its pellet after
responding correctly. Ube3am−/p+ rats took approxi-
mately twice as long as wildtypes to collect rewards
(Fig. 5h t(1, 12)= 6.918, p < 0.0001). Learning and memory
as assessed in the novel object recognition test was not
affected (Fig. S4). Both Ube3am−/p+ and Ube3am+/p+ rats
spent significantly more time investigating the novel
object than the familiar object as determined by auto-
mated tracking (Fig. S3a Ube3am−/p+ t= 4.428, df= 80,
p < 0.001; Ube3am+/p+ t= 5.162, df= 60, p < 0.001) and
hand-scoring (Fig. S3b Ube3am−/p+ t(1, 80)= 5.005, p <
0.001; Ube3am+/p+ t(1,60)= 4.832, p < 0.001).
Discussion
Genetically engineered rat models are becoming a
widely feasible investigative approach for preclinical
research that retains a high degree of genetic conservation
relative to humans for targeted therapeutic development
while providing enhanced behavioral capabilities relative
to mice. In addition to the species advantages, this is the
first model to be null for the entire Ube3a gene. Since the
gene that is causal in AS is known to be UBE3A, several
innovative gene correction strategies are being pursued
for AS and UBE3A/UBE3A replacement. In order to
measure whether therapeutic methods have efficacy, clear
and robust functional phenotypes are required. The
results presented here address this unmet need in AS
research by providing a novel rat model system with a
complete gene deletion and quantifying behavioral and
anatomical characteristics that can be used to test the
efficacy of therapeutics.
Gene targeted therapeutic approaches, including anti-
sense oligonucleotides23, viral vector delivery24, and arti-
ficial transcription factors (ATFs)25,26, are being tested for
application to AS. Other innovative methodologies that
are currently being pursued include gene-modifying
CRISPR-dCas9 and cross correction of UBE3A by
hematopoietic stem cells27. In addition to UBE3A targeted
therapies, numerous dietary and traditional pharmaceu-
tical treatments have shown alleviation of one or more
symptom domains found in the mouse model, including
but not limited to ketone esters28, dietary methylation,
ErbB inhibitors29, and topoisomerase inhibitor drugs30.
Behavioral rescues have been reported utilizing the ori-
ginal exon-2 deletion mouse from Jiang and Beaudet
backcrossed onto the C57BL6/J23,31,32 and maintained by
the Jackson Laboratory, or a genetic-based tamoxifen-
induced conditional hypomorphic line on a 129-based
mixed background backcrossed to a sub-strain of
C57BL6 in the Elgersma group33–35. Reports of rescue
have relied heavily on outcomes of the rotarod, marble-
burying, elevated plus and zero maze tasks of conflict
anxiety, and contextual fear conditioning. These tasks
are well standardized, but may lack translational pre-
dictive value and may underlie some of the large gap
between basic scientific research and translation to
therapeutics, given the lack of compound approval for
the AS community to date.
Our results illustrate a robust phenotype and impair-
ment in developmental ultrasonic vocalizations (USV), a
clear social communication readout in models of neuro-
developmental disorders (NDD). Some Angelman syn-
drome mouse models have demonstrated USV
dysregulation. One study reported increased USV emis-
sion. The reported results were highly dependent on the
mouse’s inbred background strain, and conclusions varied
across publications36,37. Our results, which highlight
reduced USV emission, were reproduced by two inde-
pendent laboratories (UC Davis MIND and Baylor College
of Medicine) and align with the AS clinical profile of
reduced communication. Moreover, given the outbred
nature of the rat over the mouse, phenotypes are likely
more generalizable by inherent natural genetic variation,
which is proving to be a successful approach in neuro-
degenerative disorder research38. Signal to noise ratio and
assay sensitivity have plagued bench-to-bedside drug
development efforts across neurodevelopmental and
Berg et al. Translational Psychiatry           (2020) 10:39 Page 7 of 16
neurodegenerative disorders, an issue that may be alle-
viated by this novel rodent species approach.
We discovered impairments in juvenile behavioral
responses to the playback of 50-kHz USV, a positive
affiliative social contact call associated with play and social
interactions, in the Ube3am−/p+ rats. Social exploratory
and approach behaviors, typically evoked by the social
contact calls, were weak in rats with the Ube3am−/p+
deletion. They did not exhibit as highly elevated distance
traveled nor extended durations of the behavioral response
compared to that of wildtype littermate controls. Wildtype
rats spent significantly longer on the arms proximal to the
speaker upon initial playback of the 50-kHz USV (i.e.,
hearing it) and for minutes after the 50-kHz USV stopped
being played (i.e., after hearing it), suggesting that they
kept searching for the conspecific even after 50-kHz USV
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Fig. 5 Delayed touchscreen learning in Ube3am−/p+ rats. a Representative image of a subject rat performing the touchscreen pairwise
discrimination. b Ube3am−/p+ adult rats took significantly longer to learn the correct response compared to wildtype littermates, requiring c more
sessions, d more trials, e more incorrect responses, and f more correction trials to reach criterion. g The average number of trials completed
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emission ended. In contrast to the wildtype, Ube3am−/p+
subjects failed to show a strong, sustained response to
hearing the cue and only spent significantly more time on
the proximal arms during the time period the audio cue
was “on”. This was an unusual display of social behavior as
there should be (1) a clear behavioral preference for the
proximal versus distal arms and (2) sustained attempts to
locate the source of the emission, as previously reported
across genetic models and groups12,15,18,20,39. The beha-
vioral alterations displayed by Ube3am−/p+ rats in
response to pro-social 50-kHz USV were clear and sub-
stantially more prominent than the social communication
deficits seen in other recently developed rat models rele-
vant to autism, including Shank315 and Cacna1c18,19.
While individuals with AS are typically thought of as being
highly social, and/or uninhibited socially, with excessive
smiling being a hallmark behavioral feature in AS, aberrant
social behavior is considered a core phenotypic trait. Thus,
the absence of typical social approach to the acoustic call is
an interesting discovered abnormality. Of additional
potential will be the in-depth investigation of whether the
social communication deficit shall be attributed to a lack
of understanding of the 50-kHz USV call (i.e., resulting
from cognitive circuit disruption) or a requirement for
longer bouts of stimulation than tested on this initial series
of experiments (i.e., resulting from impairments in moti-
vation circuits). Other testable hypotheses include
impaired sustained attention. Future directions will be
focused on the detailed nuance of this social behavior and
deciphering the response calls during the playback assay.
These functional findings of reduced USV and response to
USV are critical to the AS community in positioning for an
FDA approved clinical trial with a communication out-
come, now that two preclinical developmental time points,
postnatal life and juveniles, illustrate preclinical deficient
USV. This lower signal in communication will open new
opportunities to test therapeutics as most individuals with
AS do not ever develop speech or more than a few voca-
lizations40–42.
Movement disorders affect nearly every individual with
AS40,41,43,44. The most common motor problems include
spasticity, ataxia of gait (observed in the majority of
ambulatory individuals), tremor, and muscle weakness45.
We observed motor deficits in vertical rearing at two
different time points across development, however gross
overall motor ability to navigate an open field was unal-
tered. Low counts in vertical rearing may indicate hin-
dlimb weaknesses. We also observed motor coordination
dysfunction in young subjects on the rotarod. Motor
deficits have been key in the study of mouse models of AS,
as dysfunction on the rotarod and fewer rearing move-
ments have been one of the most consistently reported
motor behavioral phenotypes when using the C57BL6/
J46–48 but not in the 129/SvEv background strain AS mice.
Observation of these motor deficits in the genetically
heterogenous rat model extends the theory that pre-
clinical data can generalize to genetically diverse clinical
populations49. A secondary advantage of this unique
motor phenotype in rat models is the added value of a
larger species. While Ube3am−/p+ rats show motor phe-
notypes that support its use for future pharmacological/
gene therapy rescue studies, these hindlimb coordination
motor deficits do not confound other behavioral measures
such as social communication and learning and memory.
Motor confounds have plagued the interpretation of
complex behaviors for numerous neurodevelopmental
disorder mouse models, such as those of Phelan-
McDermid and Timothy syndromes50–52, yet by using a
larger species, motor deficits can be delineated and
detected without affecting other measures.
Our imaging data highlighted a wide variety of volu-
metric abnormalities. The majority of regions decreased
in size from 3 to 5%. Several differences were seen at q <
0.10, including, but not limited to, the cortex, several
white matter structures, and the cerebellum. This does
highlight the expected microcephaly although merely by a
trend. Our full group showed 3.5% reduction but only was
p= 0.06, q= 0.10, leading to our conclusion of no dif-
ferences in total brain volume at PND 21. This could be
the result of the juvenile age at image acquisition as
clinically microcephaly develops over the first 3 years of
life in AS individuals and is not 100% penetrant43,53. Fiber
tracts throughout the brain show an insignificant loss in
size in the Ube3am−/p+ rats (−3.2% in the corpus callo-
sum, −4.0% in the fimbria, and −4.3% in the arbor vita of
the cerebellum). However, when the total brain volume is
accounted for, there is a slight increase in the volume of
the fiber tracts, particularly in the fimbria, fornix, and
cerebral peduncle. Interestingly, the effect on the white
matter at postnatal day 21 appeared minimal in the
Ube3am−/p+ rats, in contrast to what has been shown in
adult exon-2 deletion mice54. While the overall cortical
losses seem to be consistent between our work and the
earlier mouse study, Judson et al. report volume losses of
11–13% in several white matter regions throughout the
brain of Ube3am−/p+mice, whereas we discovered modest
2–5% differences here for the same white matter tracts.
While the white matter findings were not as drastic as
those shown in the previous work with mice, it will be
interesting to examine the rats using diffusion tensor
imaging (DTI) to see if that technique is more sensitive to
the white matter differences seen with the mouse model.
In comparison to other rodent mouse models related to
intellectual disability and autism, the Ube3am−/p+ seems
to closely resemble the Magel2 mouse55,56, which also
displayed a 3.4% decrease in total brain volume and
similar volume differences in structures throughout the
brain ranging from −4 to 5%, including the
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parietotemporal lobe, the amygdala, and the dentate gyrus
of the hippocampus. All of these regions had similar dif-
ferences on the order of −3 to 5% in the Ube3am−/p+ rat
but did not reach significance at current thresholds. This
is likely due to the increased variability for regions in the
outbred rat versus a congenic wildtype C57Bl/6J mouse.
In an average region in a wildtype C57Bl/6J mouse one
standard deviation for a combined sex group of 20 mice is
~6%, but in the wildtype rat here it is ~8.4%. A recent
clustering analysis by Ellegood et al. examined 26 different
mouse models related to autism and clustered them into
three different groups57. Group 2 in that study was
characterized by smaller cortical and white matter struc-
tures throughout the brain consistent with what has been
shown here in the Ube3am−/p+ rat model. Other models
in Group 2 were the 15q11-13 duplication58, Itgb359,
Slc6a4 Ala56 KI60, and the humanized Androgen Recep-
tor mouse61.
Learning and memory impairments have been observed
in some but not all studies of Ube3a mutant mouse
models depending on the background strain and age at
time of testing46,47. The preponderance of these findings
used standard assessments such as the electro-
physiological correlate of learning and memory, long-
term potentiation, and behavioral assays, including Morris
water maze and contextual fear conditioning29,62–67.
Cognitive dysfunction was also postulated by enhanced
operant extinction68 and touchscreen visual discrimina-
tion in the exon-2 deletion mouse model67, albeit this
exon-2 line has prominent motor deficits that complicate
delineation of cognitive versus motor. Moreover, fre-
quently, learning and memory deficits in the mouse model
were not observed or reproduced. We expanded and
improved the translational value by using computerized-
based touchscreen technology and illustrating robust
deficits in visual discrimination of two novel equi-
luminescent stimuli in Ube3am−/p+ rats. The dis-
crimination deficit in the Ube3am−/p+ rats has transla-
tional value via the touchscreen methodology, which is
utilized by clinicians using Cogmed™ or the NIH Tool-
box® computerized-based testing batteries for many
domains of learning and memory and executive function
in several genetic NDD69–71, and will allow for testing of
cognitive enhancing agents, as well as the cognitive
domain by gene therapies. Our data make an interesting
observation in the Ube3am−/p+ rat beyond the obvious
learning deficit: we also saw longer timings to collect food
rewards upon correct responses, which has been sug-
gested as evidence of impaired motivational circuity.
While one metric of impaired motivation may be a fluke,
this elevated latency to collect reward was supported by
the lack of social approach in the playback assay. Com-
bined, these data make a stronger statement about
reduced motivation in the AS rat model. Of course, this is
our first characterization and we will have to perform
more assays specific to the motivational domain in order
to more definitively make this conclusion. We have also
been trying differing flavors of pellet rewards (chocolate,
banana, sucrose) to gather more data on motivational
components of the behavioral deficits, as motivation is
clearly not a problem in the AS clinical population for
neither learning nor social assessments.
The pipeline of translation from preclinical studies to
clinical trial is highly unique and varies greatly depending
on the type of therapy (pharmaceutical, biological, genetic
therapy) and prior research performed. For example,
some traditional medicines may be re-purposed when-
safety data is already published and known, however, for
precision medicine genetic therapies, more work on the
safety and tolerability end is required. In our experience,
to date, the first steps are to show functional efficacy of
the compound in a preclinical model and to illustrate a
lack of toxicity and sufficient safety in a secondary species.
Then, our ability to manufacture said novel therapeutic at
levels of human doses, generated in a good manufacturing
process facility, needs to be demonstrated. This, com-
bined with therapeutic profile, pharmacokinetics, phar-
macodynamics, and therapeutic kinetics would be put
together for an innovative drug discovery (IND) applica-
tion for the Food and Drug Administration (FDA) for
clinical trial approval. Currently for AS, preclinical testing
is ongoing for viral vectors, antisense oligonucleotides,
artificial transcription factors, and stem cell delivered viral
vectors and proteins, as well as simpler therapeutics from
pharmaceutical companies. Each has a unique pathway to
clinical trial.
Going forward, for successful translation to clinical
trials, targeted treatments need to improve functional
behavioral outcomes relevant to Angelman syndrome to
improve the likelihood of translational success and receive
FDA approval to conduct a clinical trial. Our report
describes, for the first time, a novel model for Angelman
syndrome that exhibits translationally relevant functional
behavioral and anatomical outcomes resulting from a full
deletion of Ube3a. The data presented are therefore
highly relevant and important for the advancement of
testing genetic and pharmacological therapeutics for
Angelman syndrome.
Methods
Subjects
All animals were housed in a temperature-controlled
vivarium maintained on a 12:12 light–dark cycle. All
procedures were conducted in compliance with the NIH
Guidelines for the Care and Use of Laboratory Animals
and approved by the Institutional Animal Care and Use
Committee of UC Davis. Ube3am+/p− males were bred
with wildtype (Ube3am+/p+) Sprague-Dawley females
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purchased from Envigo (East Millstone, New Jersey, USA)
in a conventional rat vivarium at UC Davis. The resulting
female paternally inherited rats (Ube3am+/p−) and male
wildtype (Ube3am+/p+) rats were paired for breeding to
generate maternally inherited mutants (Ube3am−/p+) and
wildtype (Ube3am+/p+) offspring for behavioral and ana-
tomical testing. Male paternally inherited mutant
(Ube3am+/p−) and female wildtype (Ube3am+/p+) rats
were also paired for breeding to generate paternally
inherited rats (Ube3am+/p−) and wildtype (Ube3am+/p+)
for colony maintenance and control testing. To identify
rats, pups were labeled via paw tattoo on postnatal day
(PND) 2 with non-toxic animal tattoo ink (Ketchum
Manufacturing Inc., Brockville, ON, Canada). A 23-gauge
needle was used to subcutaneously insert the ink into the
center of the paw. Rats were additionally identified at
weaning via tail-marks made with permanent marker.
Tattoos and tail-marks were coded to allow investigators
to run and score behaviors blind to genotype. At PND 2,
tissue samples were collected for genotyping via a small
tail snip. Genotyping was performed with REDExtract-
N-Amp (Sigma Aldrich, St. Louis, MO, USA) using
primers Rube1123 TAGTGCTGAGGCACTGGTTCA
GAGC, Rube1606r TGCAAGGGGTAGCTTACTCAT
AGC, Ub3aDelSpcfcF6 ACCTAGCCCAAAGCCATC
TC, and Ub3aDelR2 GGGAACAGCAAAAGACATGG.
Western blots
Rats were cervically dislocated and discrete brain
structures were rapidly removed using a 4 × 4 mm
matrix. Protein was extracted using RIPA buffer+ 1%
protease inhibitor. Extracted protein was quantitated
using BCA assay (ThermoFisher, Waltham, MA). Forty
micrograms of protein was denatured with 5x loading
dye (National Diagnostics) for 5 min at 95 °C and
separated on a 10% Bis-Tris Gel (BioRad, Hercules,
CA). Overnight transfer was performed at 30 V to
polyvinylidene difluoride (PVDF) membranes (Invitro-
gen, Carlsbad, CA). PVDF membranes were blocked for
45 min with Tris-buffered saline with Tween (TBST)
(1x TBS+ 0.1% Tween-20) with 5% seablock. Following
blocking, PVDF membranes were incubated with ms-
UBE3a (1:1000, Sigma 8655) and rb-beta Tubulin
(1:2000) in 5% seablock TBST for 2 h at room tem-
perature (RT). Following incubation, membranes were
washed with TBST 3x for 5 min. PVDF were then
incubated with Donkey anti-mouse LICOR 680 (1:2000)
and donkey anti-rabbit LICOR 800 (1:2000) in 5%
seablock TBST for 2 h at RT. Following incubation, gels
were washed 2x with TBST before being stored in 1x
TBS. PVDF membranes were imaged on a LICOR
Odyssey. Densitometry analysis were performed using
ImageJ (NIH, Bethesda, MD).
Cohort 1 behavioral assays
Pup ultrasonic vocalizations (USV)
On PND 4, 6, 8, 10, 12, 14, 16, and 18, isolation-induced
USV were collected for 3 min as previously described15.
Each pup, randomly selected from the nest, was placed in
a small container with clean bedding and calls were
recorded within a sound-attenuating chamber using an
ultrasonic microphone and Avisoft-RECORDER software
(Avisoft Bioacoustics, Glienicke, Germany). Immediately
following, body temperature and weight were measured.
Call spectrograms were displayed using Avisoft-SASLab
Pro and counted manually by a trained investigator blind
to genotype. Pup calls were also collected at Baylor Col-
lege of Medicine on PND 8 for 2 min over the 3 min
protocol used at the UC Davis facility. Calls were recorded
within a sound-attenuating chamber using an ultrasonic
microphone and Noldus Ultravox XT 3.2 (Noldus,
Wageningen, The Netherlands).
Developmental milestones
In a separate group of animals, on PND 4, 6, 8, 10, 12,
14, 16, and 18, developmental milestones were assessed as
described previously1. Body weight, body length, tail
length, and head width were measured with a scale and
sliding ruler. Righting reflex was tested by placing each
pup on its back and measuring the time taken to flip over
onto all four paws. The average of two trials was recorded.
Circle traverse was tested by placing each pup in the
center of a circle (12.5 cm d) and measuring the time
taken to fully exit the circle. Cliff avoidance was tested by
placing each pup near the edge of a table, with its nose
just beyond the edge, and measuring the time taken to
make a 90 degree turn away from the cliff, thereby
becoming parallel with the table edge. Each pup was
allotted 30 sec to complete each task and failure to
complete a task was recorded as the maximum score of
30 sec. The first day in which rooting reflex, forelimb
grasping, and bar hold were demonstrated was recorded.
Rooting reflex was measured as a turn of the head to
whisker stimulation. Forelimb grasping was measured as
grasping of a bar being moved upward along both front
paws. Bar hold was measured as a pup’s ability to hold
onto a bar with their front paws and support their body
weight for at least ten seconds. Day of eye opening was
also recorded.
Open field locomotion
At PND 19 and again at PND 39–44, exploratory
activity in a novel open arena was evaluated as described
previously15,72. Each animal was placed in an Accuscan
Animal Activity Monitor (Omnitech Electronics, Colum-
bus, OH, USA), which automatically measured beam
breaks for cm2 of movement via horizontal activity, ver-
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tical activity, time in center, and total distance moved over
a 30-min session.
Novel object recognition
At PND 45–53, novel object recognition was assessed
using methods similar to those described pre-
viously51,73,74. Rats were given 30min to freely explore an
empty arena (54.1 cm l × 54.1 cmw × 34.3 cm h) on 2
consecutive days. After the second exploration session,
two identical objects were placed in the arena with the
subject and the rat was allowed 10min to investigate and
become familiar with the objects. Following a 60-min
isolation, the rat was placed back in the arena (clean) with
one familiar and one novel object (both clean) and
allowed 5min to investigate.
Touchscreen pairwise discrimination
Starting at PND 65–72, pairwise visual discrimination
was tested in an automated Bussey-Saksida touchscreen
system (Lafayette Instrument, Lafayette, IN, USA) using a
procedure modified for rats from those described pre-
viously in mice50,75–77. Rats were food restricted to 85% of
their free-feeding weight. An efficient pre-training pro-
cedure based on previously published work was utilized.
The pre-training consisted of five stages to train rats to
touch the screen, collect the reward, and initiate trials.
Stage 1 consisted of a 20-min habituation to the chamber
and the sucrose pellet reinforcer with no light or images
on the screen. All following sessions lasted 30min. During
Stage 2, three sucrose pellets were dispensed upon the
screen being touched, and one pellet was dispensed if the
screen was not touched. Stage 2 lasted 5 days, until rats
completed an average of 30 trials in the 30min session.
During Stage 3, one sucrose pellet was dispensed upon the
screen being touched, and no pellets were dispensed if the
screen was not touched. Stage 3 lasted 2 days, until rats
completed an average of 30 trials during the 30 min ses-
sion. During Stage 4, rats were required to initiate each
trial by entering and exiting the food magazine. One
sucrose pellet was dispensed upon the screen being tou-
ched, and no pellets were dispensed if the screen was not
touched. Stage 4 lasted 1 day, until rats completed an
average of 30 trials in the 30min session. During Stage 5,
a random image from a set of 40 images was presented in
one of the windows until the screen was touched. One
pellet was dispensed if the image was touched, while
touching the blank side was discouraged by no reward and
by a 5-sec timeout during which an overhead light was
turned on. Stage 5 lasted 3 days, until every rat completed
at least 30 trials with an average accuracy of at least 80%
over two consecutive sessions. Images used in Stages 4
and 5 were not used in the subsequent pairwise visual
discrimination task and successful completion of all five
stages of pre-training was required for participation in the
discrimination task. Rats were trained to discriminate
between two novel images (spider and plane) displayed in
two side-by-side windows in a pseudo-randomized order.
Each 30 min session consisted of an unlimited number of
trials separated by a 20-sec intertrial interval. The image
designated as correct was counterbalanced across rats
within each genotype. Touching the correct image was
rewarded with a sucrose pellet while touching the incor-
rect image was discouraged with no pellet and a 5-sec
timeout with the light on. Incorrect responses were
immediately followed by correction trials in which the
images were presented in the identical manner to the
previous trial until the rat selected the correct image.
Successful acquisition was defined as achieving at least
80% correct responses over two consecutive sessions with
a minimum of 30 trials completed during each 30 min
session.
Cohort 2 behavioral assays
Developmental milestones
On PND 4, 6, 8, 10, 12, 14, 16, and 18, developmental
milestones were assessed as described previously73.
Negative geotaxis was tested by placing each pup on an
angled screen (45 degrees) facing downwards and mea-
suring the time taken to make a complete 180 degree turn
up the screen. The maximum time allowed was 30 sec.
Playback of pro-social 50-kHz USV
On PND 26–33, behavioral response to playback of pro-
social 50-kHz USV was used to identify if Ube3am−/p+
would exhibit similar social exploratory behaviors as
Ube3am+/p+ in response to social contact calls. The
procedure was performed as previously described15. All
rats were handled for 2 days prior to testing in a stan-
dardized manner (5 min per rat per day). Social explora-
tory and approach behavior in response to playback of
pro-social 50-kHz USV was assessed on an elevated radial
eight-arm maze (48.0 cm above floor; arms: 40.0 cm l x
10.0 cmw) surrounded by a black curtain under indirect
dim white light (8 lux) according to a modified protocol
previously established12,15,19. Acoustic stimuli were pre-
sented through Ultra-SoundGate 116 Player (Avisoft
Bioacoustics) connected to an ultrasonic loudspeaker
(ScanSpeak, Avisoft Bioacoustics) placed 20 cm away from
the end of one arm. An additional, but inactive loud-
speaker was arranged symmetrically at the opposite arm
as a visual control. Two acoustic stimuli were used: (1)
pro-social 50-kHz USV and (2) White Noise; the latter
serving as a time- and amplitude-matched acoustic sti-
mulus control20. Pro-social 50-kHz USV used for play-
back were recorded from a naive male rat during
exploration of a cage containing scents from a recently
separated cage mate. The 50-kHz USV stimulus consisted
of 221 natural 50-kHz USV (total calling time: 15.3 sec),
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composed of a sequence of 3.5 sec, which was repeated for
1 min, that is, 17 times, to assure the presentation of a
high number of frequency-modulated calls within a rela-
tively short period of time. After an initial 15-min habi-
tuation period, each rat was exposed to 1-min playback
presentations of 50-kHz USV and White Noise, separated
by a 10-min inter-stimulus interval. Stimulus order was
counterbalanced to account for possible sequence effects.
The session ended after an additional 10-min post-sti-
mulus phase (total test duration: 37-min period). Behavior
was monitored by a video camera mounted 1.7 m cen-
trally above the arena and analyzed using EthoVision XT
10 (Noldus, Wageningen, The Netherlands). Distance
traveled served as a measure for locomotor activity. Time
spent on arms proximal and distal to the active ultrasonic
loudspeaker served as measures for stimulus-directed
locomotor activity20.
Accelerating rotarod
To corroborate and reproduce the Nash laboratory
report, at PND 43–45, motor coordination, balance, and
motor learning were tested with an accelerating rotarod
(Ugo Basile, Gemonio, Italy) as described previously2,3.
Rats were placed on a rotating cylinder that slowly
accelerated from 5 to 40 revolutions per min over 5 min.
Rats were given three trials per day with a 45–60-min
intertrial rest interval and tested for 3 consecutive days for
a total of nine trials. Performance was scored as latency to
fall off the cylinder with a maximum latency of 5 min.
Adhesive removal
At PND 52, a task of adhesive removal was used to
assess sensory and find motor ability using a previously
described mouse protocol modified for rats78. Rats indi-
vidually habituated to an observation arena for 10 min and
then a small round adhesive sticker (0.64 cm d; Avery
Products Corporation, Strongsville, OH) was placed on
the forehead. The latency to initiate removal of the sticker
and the total elapsed time until complete removal of the
sticker were recorded.
Magnetic resonance imaging
A multi-channel 7.0 Tesla MRI scanner (Agilent Inc.,
Palo Alto, CA) was used to image the rat brains within
their skulls. Seven brains were scanned in one session,
using an array of millipede coils and a T2 weighted 3D
Fast Spin Echo Sequence (FSE) with an echo train length
of 12 and a cylindrical sampling of k-space to reduce
acquisition time79. Other sequence parameters included:
TR of 350 ms, echo spacing of 10.5 ms, with the center of
k-space acquired in successive averages on the 5th and the
6th echo, FOV of 3.6 × 3.6 × 4.0 and a matrix size of 456 ×
456 × 504, yielding an image resolution of 79 μm isotropic.
Total imaging time for this protocol is ~3 h and 20 min.
To visualize and compare any changes in the rat brains,
the images are linearly (6 followed by 12 parameters) and
non-linearly registered together. Registrations were per-
formed with a combination of mni_autoreg tools and
ANTS (advanced normalization tools)80,81. All scans are
then resampled with the appropriate transform and
averaged to create a population atlas representing the
average anatomy of the study sample. The result of the
registration was to deform all images into alignment
with each other in an unbiased fashion. For the volume
measurements, this allowed us to analyze the deforma-
tions needed to take each individual rat brain’s82 anat-
omy into this final atlas space, the goal being to model
how the deformation fields relate to genotype. The
Jacobian determinants of the deformation fields were
then calculated as measures of volume at each voxel.
Significant volume changes could then be calculated by
warping a pre-existing rat MRI atlas onto the population
atlas. An open-source classified atlas for the Fischer-344
rat brain has been created and maintained by the Near
Lab at the Douglas Institute in Montreal, QC (https://
www.nearlab.xyz/fischer344atlas). This segmented atlas
allowed us to assess the volume of 98 different seg-
mented structures83, encompassing the cortex, large
white matter structures (i.e., corpus callosum), ven-
tricles, cerebellum, brain stem and olfactory bulbs in all
brains. Further, these measurements could be examined
on a voxelwise basis to localize the differences found
within regions or across the brain. Multiple compar-
isons in this study were controlled for using the false
discovery rate84. We reported combined sex results in
the main text.
Statistical analysis
Developmental assays were analyzed with two-way
repeated measures ANOVA, with genotype as the
between-group factor and time as the within-group factor.
Touchscreen parameters (sessions to reach criterion,
trials to criterion, errors to criterion, and correction trials
to criterion) were analyzed with unpaired (Student’s) t-
test. Log-rank (Mantel-Cox) test was used to analyze the
percentage of animals that reached criteria in the survival/
completion analysis for the touchscreen test. Open field
parameters (horizontal activity, vertical activity, and cen-
ter time) were analyzed with two-way repeated measures
ANOVA, with genotype as the between-group factor and
time as the within-group factor. Comparisons between
time sniffing the novel object were compared within each
genotype, as previously described73,85. Data were analyzed
with Graphpad Prism. All significance levels were set at p
< 0.05 and all t-tests were two-tailed. Groups sizes were
chosen based on past experience and power analyses86.
Significant ANOVAs were followed by Bonferroni-Dunn
or Holm-Sidak posthoc testing. Behavioral data passed
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distribution normality tests, were collected using con-
tinuous variables, and thus were analyzed via parametric
analysis in all assays. For all behavioral analyses, variances
were similar between groups and data points within
2 standard deviations of the mean were included in ana-
lysis. For the MRI analysis, separate linear models were
measured for both absolute and relative regional and
voxelwise volumes. Additionally, a final linear model was
used to determine if there were any sex by genotype
interactions. In all cases, multiple comparisons were
controlled for using the false discovery rate84. Anatomical
results reported combined both sexes.
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